Completed
Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)
NCT00759135
- Conditions
- Benign Prostatic Hyperplasia (BPH), Enlarged Prostate, Genital Diseases, +5 more
- Locations
-
- Nymox Investigational Site Huntsville, Alabama, United States
- Nymox Investigational Site Tucson, Arizona, United States
- Nymox Investigational Site Little Rock, Arkansas, United States
- Nymox Investigational Site Anaheim, California, United States